Aurinia Pharmaceuticals Inc. financial data

Symbol
AUPH on Nasdaq
Location
Edmonton, Alberta, Canada
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 530% % -3.7%
Quick Ratio 55% % 6.6%
Debt-to-equity 46% % 5.8%
Return On Equity 22% %
Return On Assets 15% %
Operating Margin 26% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131,840,559 shares -7.9%
Common Stock, Shares, Outstanding 131,841,000 shares -7.9%
Entity Public Float $800,000,000 USD -42%
Weighted Average Number of Shares Outstanding, Basic 131,808,000 shares -7.9%
Weighted Average Number of Shares Outstanding, Diluted 136,008,000 shares -6.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $265,808,000 USD 21%
Cost of Revenue $29,418,000 USD 4.7%
Research and Development Expense $29,717,000 USD 30%
General and Administrative Expense $109,571,000 USD -41%
Costs and Expenses $195,802,000 USD -23%
Operating Income (Loss) $70,006,000 USD 153%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $79,640,000 USD 116%
Income Tax Expense (Benefit) $1,803,000 USD -25%
Net Income (Loss) Attributable to Parent $77,837,000 USD 120%
Earnings Per Share, Basic 0 USD/shares 140%
Earnings Per Share, Diluted 0 USD/shares 130%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $72,889,000 USD 99%
Inventory, Net $44,793,000 USD 16%
Other Assets, Current $301,000 USD -89%
Assets, Current $438,737,000 USD -0.39%
Property, Plant and Equipment, Net $2,266,000 USD -22%
Operating Lease, Right-of-Use Asset $3,718,000 USD -11%
Other Assets, Noncurrent $93,000 USD -89%
Assets $527,528,000 USD -4%
Accounts Payable, Current $2,214,000 USD
Employee-related Liabilities, Current $9,763,000 USD -31%
Accrued Liabilities, Current $49,536,000 USD
Contract with Customer, Liability, Current $4,602,000 USD 6.9%
Liabilities, Current $76,220,000 USD -3%
Operating Lease, Liability, Noncurrent $5,119,000 USD -14%
Other Liabilities, Noncurrent $12,400,000 USD 14%
Liabilities $161,757,000 USD 0.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax $749,000 USD -95%
Retained Earnings (Accumulated Deficit) $860,162,000 USD 8.3%
Stockholders' Equity Attributable to Parent $365,771,000 USD -5.7%
Liabilities and Equity $527,528,000 USD -4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $1,300,000 USD
Net Cash Provided by (Used in) Financing Activities $49,337,000 USD -228%
Net Cash Provided by (Used in) Investing Activities $31,032,000 USD -37%
Common Stock, Shares, Issued 131,841,000 shares -7.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $17,005,000 USD -209%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $73,189,000 USD 97%
Deferred Tax Assets, Valuation Allowance $154,432,000 USD -4.6%
Deferred Tax Assets, Gross $168,535,000 USD -7.7%
Operating Lease, Liability $6,176,000 USD -11%
Depreciation $4,847,000 USD 576%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $77,473,000 USD 114%
Lessee, Operating Lease, Liability, to be Paid $7,183,000 USD -14%
Property, Plant and Equipment, Gross $5,264,000 USD 0%
Operating Lease, Liability, Current $1,057,000 USD 3.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,197,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,168,000 USD 2.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,007,000 USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,226,000 USD 2.3%
Deferred Tax Assets, Operating Loss Carryforwards $130,143,000 USD -5.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,223,000 USD -0.33%
Operating Lease, Payments $276,000 USD 4.9%
Amortization of Intangible Assets $900,000 USD 12%
Depreciation, Depletion and Amortization $4,856,000 USD 0.19%
Deferred Tax Assets, Net of Valuation Allowance $14,103,000 USD -32%
Share-based Payment Arrangement, Expense $5,919,000 USD -29%
Interest Expense $5,191,000 USD 1743%